GUTS
Fractyl Health, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$71.45M
P/E Ratio
—
EPS
$-1.81
Beta
1.19
52W High
$3.03
52W Low
$0.38
50-Day MA
$0.59
200-Day MA
$1.29
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Fractyl Health, Inc. Common Stock
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.
Fundamentals
| Revenue (TTM) | 3,000 |
| Gross Profit (TTM) | 3,000 |
| EBITDA | $-95.69M |
| Operating Margin | 0.00% |
| Return on Equity | -744.00% |
| Return on Assets | -52.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.06 |
| Price-to-Book | 7.47 |
| Price-to-Sales (TTM) | 7575.74 |
| EV/Revenue | 16846.11 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -57.10% |
| Shares Outstanding | $158.65M |
| Float | $136.13M |
| % Insiders | 1.32% |
| % Institutions | 74.92% |
Analyst Ratings
Consensus ($5.24 target)
5
Buy1
HoldData last updated: 4/8/2026